Clinical Trials List
2025-10-01 - 2035-01-20
Recruiting6
ICD-10C34.90
Malignant neoplasm of unspecified part of unspecified bronchus or lung
ICD-10C34.91
Malignant neoplasm of unspecified part of right bronchus or lung
ICD-10C34.92
Malignant neoplasm of unspecified part of left bronchus or lung
ICD-10C7A.090
Malignant carcinoid tumor of the bronchus and lung
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9162.9
Malignant neoplasm of bronchus and lung, unspecified
-
Trial Applicant
Boehringer Ingelheim
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- 莊政皓 Division of Thoracic Medicine
- 李玫萱 Division of Thoracic Medicine
- Ying-Ming Tsai Tsai Division of Thoracic Medicine
- 李岱晃 Division of Thoracic Medicine
- Inn-Wen Chong Division of Thoracic Medicine
- Chih-Jen Yang Division of Thoracic Medicine
- 郭家佑 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 楊景堯 Division of General Internal Medicine
- 吳尚俊 Division of General Internal Medicine
- Chia-Chi Lin Division of Hematology & Oncology
- 于鎧綸 Division of General Internal Medicine
- James Chih-Hsin Yang Division of Hematology & Oncology
- YEN-TING LIN Division of General Internal Medicine
- 廖斌志 Division of Hematology & Oncology
- 廖唯昱 Division of General Internal Medicine
- 張立群 Division of General Internal Medicine
- 蔡子修 Division of General Internal Medicine
- Jih-Hsiang Lee Division of Hematology & Oncology
- 錢穎群 Division of General Internal Medicine
- 徐偉勛 Division of Hematology & Oncology
- CHAO-CHI HO CHAO-CHI HO Division of General Internal Medicine
- Chong-Jen Yu Division of General Internal Medicine
- 黃俊凱 Division of General Internal Medicine
- 陳冠宇 Division of General Internal Medicine
- 許嘉林 Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 郭育筑 Division of General Internal Medicine
- 廖偉志 Division of General Internal Medicine
- Chen Chia-Hung Division of General Internal Medicine
- 陳昫元 Division of General Internal Medicine
- Wen-Chien Cheng Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 蔡文銓 Division of Others
- 陳明琮 Division of Thoracic Medicine
- 陳昱光 Division of Hematology & Oncology
- 張山岳 Division of Thoracic Medicine
- 葉人華 Division of Hematology & Oncology
- 吳世偉 Division of Thoracic Medicine
- 黃才旺 Division of Thoracic Surgery
- 劉佳鑫 Division of Thoracic Medicine
- 孟繁俊 Division of Thoracic Medicine
- 柯凱雄 Division of Radiology
- 吳俊漢 Division of Thoracic Medicine
- 陳盈潔 Division of Thoracic Medicine
- 黃敍愷 Division of Thoracic Surgery
- 沈志浩 Division of Thoracic Medicine
- 賴學緯 Division of Hematology & Oncology
- 簡志峯 Division of Thoracic Medicine
- 鄭立廷 Division of Thoracic Medicine
- 王勝輝 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Hsu-ching Huang Division of Thoracic Medicine
- Chi-Lu Chiang Division of Thoracic Medicine
- 廖映庭 Division of Thoracic Medicine
- 趙恒勝 Division of Thoracic Medicine
- Yung-Hung Luo Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 枋岳甫 Division of Thoracic Medicine
- Chien-Ying Liu Division of Hematology & Oncology
- Chih-Hung Chen Division of Hematology & Oncology
- 吳浩銘 Division of Thoracic Medicine
- 邱立忠 Division of Thoracic Medicine
- Chih-Liang Wang Division of Hematology & Oncology
- Jia-Shiuan Ju Division of Hematology & Oncology
- Shih-Hong Li Division of Hematology & Oncology
- Ping-Chih Hsu Division of Hematology & Oncology
- 林定佑 Division of Hematology & Oncology
- 黃世緯 Division of Thoracic Medicine
- Chih-Hsi Kuo Division of Hematology & Oncology
- 柯皓文 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
14-20 participants
-
Global
400 participants
